Adaptive Biotechnologies Revenue, Growth & Competitor Profile

DBA ADAPTIVE

Company Profile & Annual Report for Adaptive Biotechnologies

Access the complete profile.

Adaptive Biotechnologies Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	Suite 200 1551, Eastlake Avenue East Seattle, WA 98102

Note: Revenues for privately held companies are statistical evaluations.


Adaptive Biotechnologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Adaptive Biotechnologies's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Adaptive Biotechnologies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Adaptive Biotechnologies Annual Revenue and Growth Rate

Adaptive Biotechnologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Adaptive Biotechnologies's revenues are gauged from an analysis of company filings.

Adaptive Biotechnologies's Income Statement (based on Industry Averages)

Adaptive Biotechnologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Adaptive Biotechnologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 11, 2015	16	100%	$195 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Adaptive Biotechnologies is developing and marketing. Adaptive Biotechnologies doesn't have any recent trademark applications, indicating Adaptive Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
T-DETECT Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection	06/03/2022
T T-DETECT Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection	01/22/2021

See all trademarks and details in the Full Report.

Market Share of Adaptive Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adaptive Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Adaptive Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FRED HUTCHINSON CANCER CENTER	Seattle, WA	100
ADAPTIVE BIOTECHNOLOGIES	Seattle, WA	14
ALLEN INSTITUTE	Seattle, WA	13
JUNO THERAPEUTICS	Seattle, WA	13
SANA BIOTECHNOLOGY	Seattle, WA	9
ULTRA SAFE NUCLEAR	Seattle, WA	5

Future Competition: Adaptive Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Adaptive Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)